TBX5 is a transcription factor which plays an essential role at different checkpoints during cardiac differentiation. However, regulatory pathways affected by TBX5 still remain ill-defined. We have applied the CRISPR/Cas9 technology using a completely plasmid-free approach to correct a heterozygous causative "loss-of function" TBX5 mutation in an iPSC line (DHMi004-A), that has been established from a patient suffering from Holt-Oram syndrome (HOS). This isogenic iPSC line, DHMi004-A-1, represents a powerful in vitro tool to dissect the regulatory pathways affected by TBX5 in HOS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.scr.2023.103126 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Direct cardiac reprogramming via combined CRISPRa-mediated endogenous Gata4 activation and exogenous Mef2c and Tbx5 expression.
Mol Ther Nucleic Acids
December 2024
McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Direct cardiac reprogramming of fibroblasts into induced cardiomyocytes (iCMs) can be achieved by ectopic expression of cardiac transcription factors (TFs) via viral vectors. However, risks like genomic mutations, viral toxicity, and immune response limited its clinical application. Transactivation of endogenous TFs emerges as an alternative approach that may partially mitigate some of the risks.
View Article and Find Full Text PDFIdentification and Functional Investigation of as a Novel Gene Underpinning Familial Atrial Fibrillation.
Diagnostics (Basel)
October 2024
Department of Cardiology, Shanghai Fifth People's Hospital, Fudan University, Shanghai 200240, China.
Atrial fibrillation (AF) signifies the most prevalent supraventricular arrhythmia in humans and may lead to cerebral stroke, cardiac failure, and even premature demise. Aggregating strong evidence points to genetic components as a cornerstone in the etiopathogenesis of familial AF. However, the genetic determinants for AF in most patients remain elusive.
View Article and Find Full Text PDFFunctional characterization vs in silico prediction for TBX5 missense and splice variants in Holt-Oram syndrome.
Genet Med
December 2024
CHU Lille, Centre de Référence des Anomalies du Développement, Lille, France; Univ Lille, CHU Lille, ULR 7364-RADEME-Maladies RAres du DÉveloppement embryonnaire et du Métabolisme, Lille, France.
Article Synopsis
- The study focuses on Holt-Oram syndrome (HOS), a condition caused by TBX5 gene variants, which lead to heart and limb abnormalities, and highlights the difficulties in predicting the effects of these genomic variants, particularly missense and splice variants.
- Functional tests on various TBX5 variants were conducted to better classify variants of uncertain significance (VUS), leading to the reclassification of 9 out of 14 as likely pathogenic and confirming their involvement in HOS.
- The findings show that bioinformatics and biological tests are essential and work together with clinical knowledge to improve genomic variant classification for rare diseases.
When the heart and hands tell a story: an intriguing case of Holt-Oram syndrome.
Egypt Heart J
September 2024
Cardiology Department, Ibn Rochd Hospital University, Casablanca, Morocco.
Article Synopsis
- - Holt-Oram syndrome is a rare genetic disorder linked to mutations in the TBX5 gene, characterized by skeletal and heart abnormalities, particularly affecting cardiac prognosis.
- - A case study of a 49-year-old patient revealed signs of congestive heart failure along with physical malformations like thumb triphalangia and scoliosis, leading to the discovery of an atrial septal defect through testing.
- - Diagnosis involves genetic testing for TBX5 mutations, and family screening is important due to its autosomal dominant inheritance pattern, emphasizing the need for awareness of upper limb anomalies associated with heart issues.
Holt-Oram Syndrome With Atrial Septal Defect.
Cureus
July 2024
Pediatrics, Sree Balaji Medical College and Hospital, Chennai, IND.
Holt-Oram syndrome is an autosomal dominant condition marked by heart and upper limb defects. Holt and Oram were the first to narrate this in 1960. Holt-Oram syndrome is the prototype of heart-hand syndromes and has recently been mapped to the long arm of chromosome 12 (12q2).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!